Title: ADAR1-Dependent RNA Editing Promotes MET and iPSC Reprogramming by Alleviating ER Stress
Authors: Guallar, D
Fuentes-Iglesias, A
Souto, Y
Ameneiro, C
Freire-Agulleiro, O
Pardavila, JA
Escudero, A
Garcia-Outeiral, V
Moreira, T
Saenz, C
Xiong, H
Liu, DB
Xiao, SD
Hou, Y
Wu, K
Torrecilla, D
Hartner, JC
Blanco, MG
Lee, LJ
Lopez, M
Walkley, CR
Wang, JL
Fidalgo, M
Issue Year: 2020
Publisher CELL PRESS
Series CELL STEM CELL:
Abstract Type 17 immune responses, typified by the production of the cytokines IL-17A and IL-17F, have been implicated in the development of type 1 diabetes in animal models and human patients, however the underlying pathogenic mechanisms have not been clearly elucidated. While previous studies show that IL-17A enhances inflammatory gene expression and cell death in mouse beta -cells and human islets, the function of IL-17F in pancreatic beta -cells is completely untested to date. Here we show that IL-17F exhibits potent pathogenic effects in mouse beta -cell lines and islets. IL-17F signals via the IL-17RA and -RC subunits in beta -cells and in combination with other inflammatory cytokines induces expression of chemokine transcripts, suppresses the expression of beta -cell identity genes and impairs glucose stimulated insulin secretion. Further IL-17F induces cell death in primary mouse islets. This occurs via Jnk, p38 and NF-kappa B dependent induction of Nos2 and is completely ablated in the presence of an inducible nitric oxide synthase (iNOS) inhibitor. Together these data indicate that IL-17F possesses similar pathogenic activities to IL-17A in mouse beta -cell lines and islets and is likely to be a type 17 associated pathogenic factor in type 1 diabetes.
URI: https://publications.svi.edu.au/publications/7077
Other Identifiers 10.1016/j.stem.2020.04.016
Publication type Article